HOXA11‐AS regulates JAK‐STAT pathway by miR‐15a‐3p/STAT3 axis to promote the growth and metastasis in liver cancer

Over-expression of miR-15a-3p enhances the radiosensitivity of cervical cancer by targeting tumor protein D52

(2018) Yaqin Wu et al.   BIOMEDICINE & PHARMACOTHERAPY

LncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p

(2018) Meixiao Zhan et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

HOXA11-AS promotes the growth and invasion of renal cancer by sponging miR-146b-5p to upregulate MMP16 expression

(2018) Feng-Qiang Yang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

HOXA11 antisense long noncoding RNA (HOXA11-AS): A promising lncRNA in human cancers

(2018) Cheng-Wei Lu et al.   Cancer Medicine

MicroRNA-590-5p represses proliferation of human fetal airway smooth muscle cells by targeting signal transducer and activator of transcription 3

(2018) Shan Shi et al.   Archives of Medical Science

Downregulation of microRNA-15a-3p is correlated with clinical outcome and negatively regulates cancer proliferation and migration in human osteosarcoma

(2017) Jiyuan Shi et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer

(2017) Zhili Liu et al.   Molecular Cancer

Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signalling

(2016) M. Ilamathi et al.   BIOMEDICINE & PHARMACOTHERAPY

Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer

(2016) Shou-Hua Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Expression and clinicopathological significance of the lncRNA HOXA11-AS in colorectal cancer

(2016) Tong Li et al.   Oncology Letters

In vivo delivery of miRNAs for cancer therapy: Challenges and strategies

(2015) Yunching Chen et al.   ADVANCED DRUG DELIVERY REVIEWS

Basic biology and therapeutic implications of lncRNA

(2015) O. Khorkova et al.   ADVANCED DRUG DELIVERY REVIEWS

Revealing protein–lncRNA interaction

(2015) Fabrizio Ferrè et al.   BRIEFINGS IN BIOINFORMATICS

Liver cancer: Approaching a personalized care

(2015) Jordi Bruix et al.   JOURNAL OF HEPATOLOGY

miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells

(2015) Vildan Bozok Çetintaş et al.   TUMOR BIOLOGY

Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma

(2015) Shuqun Yang et al.   Oncotarget

Treatment of Liver Cancer

(2015) Chun-Yu Liu et al.   Cold Spring Harbor Perspectives in Medicine

Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2014) Nicholas J Kassebaum et al.   LANCET

Liver cancer

(2014) Lauren Gravitz   NATURE

Genome-Wide Analysis of Long Noncoding RNA (lncRNA) Expression in Hepatoblastoma Tissues

(2014) Rui Dong et al.   PLoS One

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

(2014) Bruna Scaggiante   WORLD JOURNAL OF GASTROENTEROLOGY

Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation

(2014) Reena V. Kartha et al.   Frontiers in Genetics

JAK/STAT3 signalling is sufficient and dominant over antagonistic cues for the establishment of naive pluripotency

(2012) Anouk L. van Oosten et al.   Nature Communications